Stay updated with breaking news from Exalenz Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global norovirus diagnostics market was valued at US$ 47.6 Mn in 2020, and is expected to exhibit a CAGR of around 8.4% between 2021-2031.
/PRNewswire/ -- As per Persistence Market Research's latest industry analysis, the global norovirus diagnostics market was valued at US$ 47.6 Mn in 2020, and...
/PRNewswire/ -- As per Persistence Market Research's latest industry analysis, the global norovirus diagnostics market was valued at US$ 47.6 Mn in 2020, and...
Message : Required fields CINCINNATI, May 07, 2021 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2021. Second Quarter 2021 Highlights (Comparison to Second Quarter Fiscal 2020): Consolidated net revenues of $85.3 million, up 49% year-over-year Life Science segment delivered net revenues of $53.3 million, up 139% year-over-year Diagnostics segment net revenues decreased 9% year-over-year to $31.9 million, up 5% from the first quarter of fiscal 2021 Signed agreement for 2nd grant from the National Institut...